Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: Design, objectives, and baseline characteristics of a prospective case-cohort study-ELSA-Brasil

Imagem de Miniatura
Arquivos
art_BENSENOR_Chronic_inflammatory_diseases_subclinical_atherosclerosis_and_cardiovascular_diseases_2022.PDF (537.91 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Autores
ALENCAR, Airlane
TELLES, Rosa W.
MACHADO, Luciana Andrade Carneiro
BARRETO, Sandhi Maria
Citação
CLINICS, v.77, article ID 100013, 7p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: This analysis describes the protocol of a study with a case-cohort to design to prospectively evaluate the incidence of subclinical atherosclerosis and Cardiovascular Disease (CVD) in Chronic Inflammatory Disease (CID) participants compared to non-diseased ones. Methods: A high-risk group for CID was defined based on data collected in all visits on self-reported medical diagnosis, use of medicines, and levels of high-sensitivity C-Reactive Protein >10 mg/L. The comparison group is the Aleatory Cohort Sample (ACS): a group with 10% of participants selected at baseline who represent the entire cohort. In both groups, specific biomarkers for DIC, markers of subclinical atherosclerosis, and CVD morbimortality will be tested using weighted Cox. Results: The high-risk group (n = 2,949; aged 53.6 +/- 9.2; 65.5% women) and the ACS (n=1543; 52.2 +/- 8.8; 54.1% women) were identified. Beyond being older and mostly women, participants in the high-risk group present low average income (29.1% vs. 24.8%, p < 0.0001), higher BMI (Kg/m2) (28.1 vs. 26.9, p < 0.0001), higher waist circumference (cm) (93.3 vs. 91, p < 0.0001), higher frequencies of hypertension (40.2% vs. 34.5%, p < 0.0001), diabetes (20.7% vs. 17%, p = 0.003) depression (5.8% vs. 3.9%, p = 0.007) and higher levels of GlycA a new inflammatory marker (p < 0.0001) compared to the ACS. Conclusions: The high-risk group selected mostly women, older, lower-income/education, higher BMI, waist circumference, and of hypertension, diabetes, depression, and higher levels of GlycA when compared to the ACS. The strategy chosen to define the high-risk group seems adequate given that multiple sociodemographic and clinical characteristics are compatible with CID.
Palavras-chave
Cardiovascular disease, Coronary artery calcium (CAC), Carotid intima-media thickness (CIMT), Fatal and non-fatal cardiovascular events
URI
https://observatorio.fm.usp.br/handle/OPI/47011
Referências
  1. AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
  2. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  3. Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X
  4. Behl T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249505
  5. Bensenor IM, 2016, AM HEART J, V174, P51, DOI 10.1016/j.ahj.2015.12.018
  6. Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
  7. Boo S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176291
  8. Brant Luisa Campos Caldeira, 2017, Rev. bras. epidemiol., V20, P116, DOI 10.1590/1980-5497201700050010
  9. Cai RX, 2020, J HYPERTENS, V38, P1632, DOI 10.1097/HJH.0000000000002442
  10. Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835
  11. Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
  12. Cooksey R, 2018, SEMIN ARTHRITIS RHEU, V48, P367, DOI 10.1016/j.semarthrit.2018.03.005
  13. Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
  14. FOURNET B, 1978, BIOCHEMISTRY-US, V17, P5206, DOI 10.1021/bi00617a021
  15. Giles JT, 2019, ARTHRITIS RHEUMATOL, V71, P1426, DOI 10.1002/art.40889
  16. Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]
  17. Gu MM, 2019, IMMUNOL INVEST, V48, P505, DOI 10.1080/08820139.2019.1567534
  18. Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55
  19. Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006
  20. Jonsson R, 2013, JAMA-J AM MED ASSOC, V310, P1854, DOI 10.1001/jama.2013.278448
  21. Kuller LH, 2014, ARTHRITIS RHEUMATOL, V66, P497, DOI 10.1002/art.38268
  22. Laurent S, 2012, ANN MED, V44, pS93, DOI 10.3109/07853890.2011.653398
  23. LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415
  24. Libby P, 2018, J AM COLL CARDIOL, V72, P2071, DOI 10.1016/j.jacc.2018.08.1043
  25. Lohman TG, ANTHROPOMETRIC STAND
  26. Lotufo PA, 2015, SAO PAULO MED J, V133, P69, DOI 10.1590/1516-3180.2015.13320018
  27. Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
  28. Myasoedova E, 2011, ANN RHEUM DIS, V70, P482, DOI 10.1136/ard.2010.135871
  29. Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022
  30. Pereira AC, 2016, CLIN CARDIOL, V39, P352, DOI 10.1002/clc.22539
  31. Pereira AC, 2013, REV SAUDE PUBL, V47, P72, DOI 10.1590/S0034-8910.2013047003822
  32. Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980
  33. PRENTICE RL, 1986, BIOMETRIKA, V73, P1
  34. Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611
  35. Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202
  36. Rivera TL, 2009, ANN RHEUM DIS, V68, P828, DOI 10.1136/ard.2008.088054
  37. Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
  38. Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7
  39. Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
  40. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  41. Sultan AA, 2015, GUT, V64, P1220, DOI 10.1136/gutjnl-2014-308285
  42. Theander E, 2015, ARTHRITIS RHEUMATOL, V67, P2427, DOI 10.1002/art.39214
  43. Treff C, 2017, J HUM HYPERTENS, V31, P278, DOI 10.1038/jhh.2016.75
  44. Tunstall-Pedoe H., 2005, PREVENTING CHRONIC D, P200
  45. World Health Organization, 2004, ICD 10 INT CLASSIFIC

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/07
Carregar mais